Literature DB >> 1082356

Alpha-1-antitrypsin: molecular abnormality of S variant.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082356      PMCID: PMC1638590          DOI: 10.1136/bmj.1.6002.130-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Basis of the defect in alpha-1-antitrypsin deficiency.

Authors:  O F Bell; R W Carrell
Journal:  Nature       Date:  1973-06-15       Impact factor: 49.962

2.  Heat lability of alpha1-antitrypsin variants.

Authors:  J Lieberman
Journal:  Chest       Date:  1973-11       Impact factor: 9.410

3.  Isolation and properties of human plasma alpha-1-proteinase inhibitor.

Authors:  R Pannell; D Johnson; J Travis
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

4.  Alpha-1-antitrypsin variants in New Zealand.

Authors:  E D Janus; P R Joyce; J M Sheat; R W Carrell
Journal:  N Z Med J       Date:  1975-11-12

5.  A partial amino acid sequence for sheep haemoblogin A.

Authors:  D Beale
Journal:  Biochem J       Date:  1967-04       Impact factor: 3.857

  5 in total
  5 in total

Review 1.  The epidemiology of alpha 1-antitrypsin deficiency.

Authors:  D C Hutchison
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Origin of the multiple components of human alpha1-antitrypsin.

Authors:  A Yoshida; M Wessels
Journal:  Biochem Genet       Date:  1978-08       Impact factor: 1.890

3.  A study of restriction fragment length polymorphisms at the human alpha-1-antitrypsin locus.

Authors:  K J Matteson; H Ostrer; A Chakravarti; K H Buetow; W E O'Brien; A L Beaudet; J A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 4.  Human gene therapy: present and future.

Authors:  M A Kay; K P Ponder; S L Woo
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 5.  Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors:  Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.